Medical Device Industry QualityCore
Comprehensive regulatory and quality management solutions for Indian market entry, specialized in MD-series licenses and ISO 13485.
Regulatory Landscape
The Indian medical device industry is a sunrise sector, driven by a growing middle class and the 'Make in India' initiative. Under the Medical Devices Rules (MDR) 2017, the CDSCO has brought all medical devices — from Class A (low risk) to Class D (high risk) — under a single regulatory umbrella.
Market access in India requires more than just clinical efficacy; it demands a robust technical dossier, an Authorized Indian Representative (AIR) for foreign makers, and a Quality Management System (QMS) that meets ISO 13485 standards. For 2024, the CDSCO has also enhanced its focus on Post-Market Surveillance (PMS).
MedRegX India provides a Turnkey Approach. We handle your device classification, dossier filing for MD-series licenses, coordinate with Notified Bodies for QMS audits, and provide end-to-end support for CDSCO portal management (SUGAM).
Market Access Roadmap
Device Classification
Categorizing your device into Class A, B, C, or D based on the 2017 Rules, which determines your fee and documentation requirements.
Dossier Compilation
Drafting the Device Master File (DMF) and Plant Master File (PMF), including risk management and performance evaluation data.
QMS Audit (ISO 13485)
Ensuring the manufacturing site is compliant with Quality Management Systems and coordinating with Notified Bodies or CDSCO for audit visits.
MD-Registration & Import License
Submitting applications through the SUGAM portal to obtain the relevant MD-series licenses (e.g., MD-15 for imports or MD-5/MD-9 for manufacturing).
Post-Market Compliance
Setting up a vigilance system for adverse event reporting and filing Periodic Safety Update Reports (PSURs) every 6-12 months.
Industry Market Access Handbook: Medical Devices & Diagnostics
The medical device and diagnostics market in India is expanding rapidly, creating massive opportunities for both global and domestic manufacturers. However, navigating the statutory gatekeeper—the Central Drugs Standard Control Organisation (CDSCO)—requires a precise understanding of the Medical Devices Rules (MDR), 2017. Under this legislation, all medical devices and In Vitro Diagnostics (IVDs) are subject to mandatory licensing based on risk classification: Class A (low risk), Class B (low-moderate risk), Class C (moderate-high risk), and Class D (high risk). To ensure a successful launch, companies must establish a robust Quality Management System (QMS) matching ISO 13485:2016 and prepare detailed technical dossiers.
For global brands entering India, appointing an Authorized Indian Representative (AIR) is legally mandated under Rule 34. The AIR acts as the local license holder and must hold a valid wholesale drug license. The application for an Import License (Form MD-15) requires the submission of an exhaustive Device Master File (DMF) and Plant Master File (PMF). This technical documentation must include raw material validation, biocompatibility studies (ISO 10993), electrical safety data (IEC 60601), and a comprehensive Clinical Evaluation Report (CER) detailing historical clinical studies or local evaluation data.
MedRegX assists medical device manufacturers and importers with end-to-end CDSCO SUGAM registration, Notified Body QMS audits, and post-market surveillance. We conduct comprehensive dossier pre-audits to guarantee that CDSCO technical reviewers find zero deficiencies, accelerating your market entry and avoiding costly rejections.
Statutory Best Practices
- Ensure your manufacturing site strictly complies with ISO 13485:2016 and cleanroom guidelines.
- Compile an exhaustive Device Master File (DMF) covering design, material, and biocompatibility specs.
- Draft product labeling mock-ups in strict compliance with Schedule VI of MDR 2017.
- Conduct a thorough gap analysis of your clinical evaluation reports (CER) to ensure data validity.
Critical Standards
| Standard / Rule | Requirement |
|---|---|
| Medical Device Rules 2017Primary Law | The overarching regulation governing the manufacture, import, sale, and distribution of medical devices in India. |
| ISO 13485:2016Quality Standard | The global benchmark for medical device QMS, recognized by India for regulatory site audits. |
| Post-Market Surveillance (PMS)Safety Standard | Mandatory system for monitoring the safety and performance of devices after they have been placed on the market. |
Frequently Asked Questions
Have questions? Find direct, humanized answers about the regulatory approvals and timelines.
Regulatory Support for the Medical Device Industry in India
India regulates every medical device under the Medical Devices Rules, 2017, administered by CDSCO. Whether you manufacture in India or import finished devices, the same first question decides your entire path — what risk class (A, B, C or D) your device falls into — and everything downstream, from the form you file to the fee you pay, follows from that answer.
Licensing for manufacturers and importers
Domestic makers of Class A and B devices apply to the State Licensing Authority for an MD-5 licence; Class C and D go to central CDSCO for an MD-9 licence after a joint plant inspection. Foreign manufacturers do not make anything here — they appoint an Authorised Indian Agent and secure an MD-15 import licence. We run both routes end to end, from CDSCO device registration to the Device Master File and Plant Master File that reviewers actually read.
A working ISO 13485 quality system is effectively a precondition, not paperwork you add later. For companies also targeting the United States, we handle the parallel FDA 510(k) route so one product programme serves both markets.
Why classification is where projects are won or lost
The single most expensive mistake in this industry is assuming a device class and discovering months later that the wrong office, the wrong form, and the wrong dossier depth were used. We classify first and file second — which is why our medical-device applications clear technical review far more often on the first attempt. If you are unsure where your device sits, an early conversation with our consultants costs nothing and saves the most.